Jeffrey Weitzel

Has grant

Professor and Director

University of Kansas Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Science Medical Science professors in United States

Contact this professor

ORCID

Google Scholar

About

Jeffrey Weitzel is a Professor and Director at the University of Kansas Cancer Center, USA. His research focuses on genetic counseling, cancer susceptibility genetics, and breast cancer risk prediction. Recent publications highlight the significance of genetic variants in cancer risk and the challenges of genetic testing in diverse populations.

Recent Grants

Grant: Close

Genetic Cancer Risk and Breast Cancer Prevention in Latin American Populations

Open Date:

Close Date:

Jeffrey Weitzel

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Educational Video as an Alternative to Pretest In-Person Genetic Counseling in Candidates for Cancer Genetic Testing: A Randomized Controlled Noninferiority Trial

A genotype-first approach identifies high incidence of NF1 pathogenic variants with distinct disease associations

Pathogenic Variants in Cancer Susceptibility Genes Predispose to Ductal Carcinoma <i>In Situ</i> of the Breast

Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic Risk

Uptake of Risk-Reducing Surgeries in an International Real-World Cohort of Hispanic Women

Poor compliance with germline testing recommendations in colorectal cancer patients undergoing molecular residual disease testing

Addressing the Historic Challenges of BRCA1 and BRCA2 Variant Curation and the Need for More Diverse Representation

Lynch syndrome in Mexican-Mestizo families: Genotype, phenotypes, and challenges in cascade testing among relatives at risk

Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer–Associated Germline Pathogenic Variants in Mexico

Hereditary cancer testing in a diverse sample across three breast imaging centers

Variable number tandem repeats (VNTRs) as modifiers of breast cancer risk in carriers of BRCA1 185delAG

Integration of a Cross-Ancestry Polygenic Model With Clinical Risk Factors Improves Breast Cancer Risk Stratification

Erratum: Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (European journal of human genetics : EJHG (2022) 30 3 (349-362))

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers.

Clonal Hematopoiesis and Mosaicism Revealed by a Multi-Tissue Analysis of Constitutional TP53 Status

Cross-sectional clinical cancer genomics community of practice survey analysis of provider attitudes and beliefs regarding the use of deceased family member tissue to guide living family member genetic cancer risk assessment

Germline pathogenic variants in Mexican patients with hereditary triple-negative breast cancer

Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast

Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set

Risk of Late-Onset Breast Cancer in Genetically Predisposed Women

Collaborators (14)

Weiva Sieh

Louise Marquart

Niclas Håkansson

Vineet Bafna

Stacy Gray

Siddhartha Yadav

Allison DePersia

Eileen Dareng

Manuel António Rodrigues Teixeira

Mary Beth Terry

Peter Mace

Lidia Feliubadaló

Natalia Bogdanova

Zdenek Kleibl

How do I reach out?

Meet Kite AI